Nasir Rahmatullah, MD
Cardiology · Kissimmee, FLNPI 1679503684
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,337 of the $1,634 with a category attached, or 81.8%. 19 manufacturers reported payments, led by Astellas Pharma US Inc at 25.5% of the total. Reporting peaked in 2021 at $442 and has fallen 72.0% since, to $124 in 2025.
Across 71 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$416
- Boehringer Ingelheim$393
- Kestra Medical Technology Services, Inc.$153
- AstraZeneca$141
- Amgen$115
- Lilly USA, LLC$56
- plus $362 from 13 others
Across 5 payments — averaging $66,588 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$333K
What the payments were for
- Food & beverage$1,33782%
- Education$29718%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $416 |
| Boehringer Ingelheim | 18 | $393 |
| Kestra Medical Technology Services, Inc. | 4 | $153 |
| AstraZeneca | 9 | $141 |
| Amgen | 8 | $115 |
| Lilly USA, LLC | 2 | $56 |
| Exact Sciences | 3 | $52 |
| Medtronic | 3 | $51 |
| Novo Nordisk | 3 | $45 |
| Johnson & Johnson | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Abbott | 1 | $27 |
| Cvrx, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Pfizer | 1 | $17 |
| Boston Scientific | 1 | $13 |
| Novartis | 1 | $13 |
| Medicomp Inc | 1 | $11 |
How this compares
$1,634 in reported general payments places this provider in the 60th percentile of 45 cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $25,165 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 63 | $1,059 |
| Amiodarone Hcl | 22 | $821 |
| Metoprolol Succinate | 35 | $722 |
| Carvedilol | 60 | $623 |
| Nitroglycerin | 21 | $541 |
| Diltiazem Hcl | 16 | $362 |
| Losartan Potassium | 25 | $256 |
| Atorvastatin Calcium | 38 | $239 |
| Enalapril Maleate | 26 | $234 |
| ClopidogrelClopidogrel Bisulfate | 24 | $140 |
| Amlodipine Besylate | 21 | $92 |
| Lisinopril | 24 | $86 |
| Furosemide | 21 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $25,16522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 45 cardiology providers in Florida.
Other cardiology in Kissimmee
- Madhusudana KalakotaKissimmee$2K
- Shakoor ArainOkeechobee$13K
- Erick CalderonLakewood Ranch$10K
- Melchor GonzalezPalm Coast$8K
- Andres PalomoMiami$7K
- Ariel de la RosaHialeah$7K
- Mayank YadavOrange City$7K
- Lawrence WeinsteinBoynton Beach$5K
- Mohsen RashdanBoca Raton$5K
- Ramanath RaoZephyrhills$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.